1.
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
by Feng, Shuo
Nature medicine, 2021-11, Vol.27 (11), p.2032-2040
2.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
by Khoury, David S
Nature medicine, 2021-07, Vol.27 (7), p.1205-1211
3.
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
by Solís Arce, Julio S
Nature medicine, 2021, Vol.27 (8), p.1385-1394
4.
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
by Tostanoski, Lisa H
Nature medicine, 2020-11, Vol.26 (11), p.1694-1700
5.
COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment
by Khubchandani, Jagdish
Journal of community health, 2021-01-03, Vol.46 (2), p.270-277
6.
Seasonal coronavirus protective immunity is short-lasting
by Eidge, Arthur W. D
Nature medicine, 2020-11, Vol.26 (11), p.1691-1693
7.
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
by Choi, Angela
Nature medicine, 2021-11, Vol.27 (11), p.2025-2031
8.
Individual preferences for COVID-19 vaccination in China
by Leng, Anli
Vaccine, 2021-01-08, Vol.39 (2), p.247-254
9.
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
by Guebre-Xabier, Mimi
Vaccine, 2020-11-25, Vol.38 (50), p.7892-7896
10.
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey
by Ruiz, Jeanette B
Vaccine, 2021-02-12, Vol.39 (7), p.1080-1086
11.
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
by Chen, Rita E
Nature medicine, 2021-04, Vol.27 (4), p.717-726
12.
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong
by Wong, Martin C.S
Vaccine, 2021-02-12, Vol.39 (7), p.1148-1156
13.
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
by Waissengrin, Barliz
The lancet oncology, 2021-05, Vol.22 (5), p.581-583
14.
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England
by Bell, Sadie
Vaccine, 2020-11-17, Vol.38 (49), p.7789-7798
15.
Modeling COVID-19 scenarios for the United States
by Reiner, Robert C., Jr
Nature medicine, 2021-01, Vol.27 (1), p.94-105
16.
Delayed production of neutralizing antibodies correlates with fatal COVID-19
by Lucas, Carolina
Nature medicine, 2021-07, Vol.27 (7), p.1178-1186
17.
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples
by Robinson, Eric
Vaccine, 2021-04-08, Vol.39 (15), p.2024-2034
18.
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use
by Shen, Mingwang
Vaccine, 2021-04-15, Vol.39 (16), p.2295-2302
19.
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
by Ura, Takehiro
Vaccine, 2021-01-08, Vol.39 (2), p.197-201
20.
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia
by Kuter, Barbara J
Vaccine, 2021-03-19, Vol.39 (12), p.1693-1700
